ESC 365 - Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM

ESC Premium Access

Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM

Session: There is no sweet spot in diabetes

Topic: Left Ventricular Remodelling

Speaker: Professor C. Lang (Dundee, GB)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Chim Choy Lang

University of Dundee, Dundee (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

5 more presentations in this session

Association between insulin resistance and coronary plaque vulnerability in patients with acute coronary syndromes: insights from optical coherence tomography

Speaker: Doctor S. Wu (Beijing, CN)

Impact of statin treatment on the prevalence of lesion vulnerability and instability features in patients with diabetes mellitus - Insights from the COMBINE (FFR-OCT) Study

Speaker: Doctor B. Berta (Kecskemet, HU)

Sex differences in mortality and rates of cardiovascular disease in patients with diabetes

Speaker: Mr M. Malmborg (Copenhagen, DK)

Impact of diabetes on 5-year clinical outcomes in stable coronary artery disease, across multiple geographical regions and ethnicities. Insights from the CLARIFY registry

Speaker: Doctor K. Mak (Singapore, SG)

Impact of chronic kidney disease on diabetic patients with stable coronary disease undergoing surgery, angioplasty or medical treatment in a ten-year follow-up.

Speaker: Mr E. Martins (Sao Paulo, BR)

Access the full session

There is no sweet spot in diabetes

Speakers: Professor C. Lang, Doctor S. Wu, Doctor B. Berta, Mr M. Malmborg, Doctor K. Mak...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources